Literature DB >> 11752860

Peyronie's disease: prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50-69 years.

G La Pera1, E S Pescatori, M Calabrese, A Boffini, F Colombo, E Andriani, A Natali, L Vaggi, C Catuogno, M Giustini, F Taggi.   

Abstract

OBJECTIVES: We present a multicenter, population-based epidemiological survey aimed at assessing the prevalence of Peyronie's disease (PD) and its potential risk factors in the general population.
METHODS: In each of the ten centers throughout Italy, a uroandrologist contacted all the men in the age range 50-69 years registered with a general practitioner (GP). The subjects recruited were evaluated on the basis of their medical history, including alcohol consumption and cigarette smoking. The following questionnaires were administered: IIEF, IIPSS symptom score, premature ejaculation and PD.
RESULTS: All the subjects registered with a GP were invited to participate in the study. Of the 1,180 subjects, 647 (53%) entered over survey. In this population, 46 cases of PD were identified, accounting for a prevalence of 7.1%. The prevalence rate increased with age even if the trend is not statistically significant. The multivariate analysis showed a significant correlation between cigarette smoking and PD, with an odds ratio (OR) of 4.6 (CL 95%) confidence limit 1.506- 14.287). Smoking as single variable had an OR of 7.2 (95% CL 2.34-24.93). No significant association was observed between PD and the other variables such as cardiovascular diseases, diabetes, hypertension and alcohol consumption.
CONCLUSIONS: PD is a much more frequent condition in the general population than previously reported. According to our results, cigarette smoking may be considered a risk factor for developing PD. If further and more targeted studies confirm that giving up smoking may reduce the risk of developing PD, then there will be new prospects for primary and secondary prevention and for curbing the progression of the disease.

Entities:  

Mesh:

Year:  2001        PMID: 11752860     DOI: 10.1159/000049830

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  21 in total

1.  PEYRONIE'S DISEASE: A REVIEW OF ETIOLOGY, DIAGNOSIS, AND MANAGEMENT.

Authors:  Aylin N Bilgutay; Alexander W Pastuszak
Journal:  Curr Sex Health Rep       Date:  2015-06-01

Review 2.  Ultrasound in patients affected with Peyronie's disease.

Authors:  P Fornara; H-P Gerbershagen
Journal:  World J Urol       Date:  2004-07-28       Impact factor: 4.226

3.  Penile Sensory Changes After Plaque Incision and Grafting Surgery for Peyronie's Disease.

Authors:  Jean E Terrier; Raanan Tal; Christian J Nelson; John P Mulhall
Journal:  J Sex Med       Date:  2018-09-06       Impact factor: 3.802

Review 4.  Outcomes of Surgery in Peyronie's Disease Following Intralesional Collagenase Clostridium Histolyticum Injections.

Authors:  Mahdi Bazzi; Marcus L Jamil; Ali A Dabaja
Journal:  Curr Urol Rep       Date:  2019-06-14       Impact factor: 3.092

5.  Testosterone Levels Are Not Associated With Magnitude of Deformity in Men With Peyronie's Disease.

Authors:  John P Mulhall; Kazuhito Matsushita; Christian J Nelson
Journal:  J Sex Med       Date:  2019-07-11       Impact factor: 3.802

6.  The direction and severity of penile curvature does not have an impact on concomitant vasculogenic erectile dysfunction in patients with Peyronie's disease.

Authors:  E C Serefoglu; L Trost; S C Sikka; W J G Hellstrom
Journal:  Int J Impot Res       Date:  2014-07-17       Impact factor: 2.896

7.  Effectiveness of antioxidants (propolis, blueberry, vitamin E) associated with verapamil in the medical management of Peyronie's disease: a study of 151 cases.

Authors:  G Paulis; R D'Ascenzo; P Nupieri; G De Giorgio; G Orsolini; T Brancato; R Alvaro
Journal:  Int J Androl       Date:  2011-09-27

8.  A Population-Based Study of Peyronie's Disease: Prevalence and Treatment Patterns in the United States.

Authors:  Dana Britt Dibenedetti; Dat Nguyen; Laurie Zografos; Ryan Ziemiecki; Xiaolei Zhou
Journal:  Adv Urol       Date:  2011-10-23

9.  ABO Blood Type and Risk of Peyronie's Disease in Japanese Males.

Authors:  Yozo Mitsui; Hideyuki Kobayashi; Fumito Yamabe; Koichi Nakajima; Koichi Nagao
Journal:  World J Mens Health       Date:  2022-01-01       Impact factor: 6.494

Review 10.  A critical analysis of the surgical outcomes for the treatment of Peyronie's disease.

Authors:  Sree H Mandava; Landon W Trost; Wayne J G Hellstrom
Journal:  Arab J Urol       Date:  2013-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.